5/15/2025

Janusmed sex and gender

Janusmed sex and gender – nirmatrelvir

Janusmed Sex and Gender is a knowledge database providing information on sex and gender aspects of drug treatment. The knowledge database is primarily intended to be used by physicians and healthcare professionals. The texts are general and should not be considered as treatment guidelines. The individual patient’s physician is responsible for the patient’s drug treatment.

Back to index
A A
A A

Nirmatrelvir

Nirmatrelvir

Class : A

Show all info

Print

Contact us

  1. Paxlovid (nirmatrelvir, ritonavir). Pfizer Europe MA EEIG. EMA EPAR Product Information. Updated 03/11/2022.

  2. EMA. Assessment report Paxlovid. EMA [www]. [updated 2021-12-16, cited 2022-04-14].

  3. Li M, Zhang QS, Liu XL, Wang HL, Liu W. Adverse Events Associated with Nirmatrelvir/Ritonavir: A Pharmacovigilance Analysis Based on FAERS. Pharmaceuticals (Basel). 2022;15(12).

  4. VAL-databasen. Region Stockholm. 2021 [cited 2023-01-20.]

  1. Paxlovid (nirmatrelvir, ritonavir). Pfizer Europe MA EEIG. EMA EPAR Product Information. Updated 03/11/2022.
  2. EMA. Assessment report Paxlovid. EMA [www]. [updated 2021-12-16, cited 2022-04-14].
  3. Li M, Zhang QS, Liu XL, Wang HL, Liu W. Adverse Events Associated with Nirmatrelvir/Ritonavir: A Pharmacovigilance Analysis Based on FAERS. Pharmaceuticals (Basel). 2022;15(12).
  4. VAL-databasen. Region Stockholm. 2021 [cited 2023-01-20.]